Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)

Guerbet

Status: Completed

Conditions: General Safety Profile of DOTAREM

Study type: Observational

Funder types: Industry

Identifiers

NCT01523873

DGD-55-001

Details and patient eligibility

About

The main purpose of this study is to prospectively assess the general safety profile of Dotarem

Enrollment: 35,921 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• patient scheduled for a Dotarem®-enhanced MRI

Exclusion criteria

• patient with a contra-indication to MR examination
• patient with a contra-indication to Dotarem® injection as per local SPC